Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Arq. bras. med. vet. zootec. (Online) ; 71(3): 1058-1066, May-June 2019. tab, graf
Article in Portuguese | VETINDEX, LILACS | ID: biblio-1011297

ABSTRACT

A suplementação proteico-energética (SPE) é uma estratégia adequada à bovinocultura de corte no período seco do ano, embora sua adoção equivocada possa comprometer seu benefício/custo. O objetivo deste estudo foi avaliar o desempenho de novilhas Nelore em pastagem diferida de Urochloa decumbens sob dois períodos de SPE, e realizar análise econômica desses sistemas de produção. O experimento foi conduzido sob delineamento inteiramente ao acaso, com 147 e 55 dias de SPE (sistemas 1 e 2, respectivamente), de 21/06 a 15/11/2016, com 16 e 20 novilhas nos sistemas 1 e 2, respectivamente. Os dados de desempenho foram analisados utilizando-se o PROC MIXED do SAS®, e as médias comparadas por PDIFF (P<0,05). Os pesos médios foram semelhantes (P>0,05) entre os sistemas de produção nas pesagens de 21/06, 12/07, 02/08, 23/08 e 15/11/2016. Os valores presentes líquidos foram positivos sob a taxa anual de desconto de 4%, sendo viáveis financeiramente. Por apresentarem taxa interna de retorno superior à taxa mínima de atratividade, os sistemas foram atrativos para investimento. Foi obtido balanço econômico positivo de R$ 25,26/animal para substituição do sistema 1 pelo sistema 2. A redução de 92 dias na SPE proporciona desempenho semelhante entre novilhas e maior eficiência econômica do sistema de produção.(AU)


Protein-energy supplementation (SPE) is an adequate strategy for beef cattle during drought season of the year, although the wrong adoption might compromise its cost/benefit ratio. The aim of this study was to evaluate Nellore heifers' performance under SPE periods and to draw economic analysis of production systems. The experiment was conducted under a completely randomized design, with two systems: 147 and 55 days of SPE (Systems 1 and 2), from 06/21/2016 to 11/15/2016, with 16 and 20 heifers to Systems 1 and 2, respectively. Performance data were analyzed by SAS® PROC MIXED and means compared by PDIFF (P< 0.05). The weight means were similar between the production systems (P> 0.05) at weighing of 06/21, 07/12, 08/02, 08/23 and 11/15/2016. The net present values were positive under annual discount rate of 4%, being financially viable. By presenting internal return rate higher than the minimum attractiveness rate, the systems were attractive for investment. Positive economic balance was obtained of R$ 25.26/animal to replace System 1 by 2. The reduction of 92 days in SPE provides similar performance between Nellore heifers and greater economic efficiency of the production system.(AU)


Subject(s)
Animals , Female , Cattle , Dietary Proteins/administration & dosage , Pasture/analysis , Diet/veterinary , Animal Feed/analysis , Animal Nutritional Physiological Phenomena
2.
Arq. bras. med. vet. zootec ; 66(2): 481-488, Jan.-Apr. 2014. graf, tab
Article in Portuguese | LILACS | ID: lil-709288

ABSTRACT

Determinou-se a melhor altura de pastejo do capim-tanzânia (Panicum maximum Jacq. cv. Tanzânia) sob lotação contínua e com taxa de lotação variável na produção de bovinos de corte. A área experimental, de 12 hectares, foi dividida em piquetes de um hectare cada, com três repetições para cada altura - 20; 40; 60 e 80cm. Foram utilizados, em cada piquete, três bovinos machos, da raça Nelore, mais animais adicionais conforme necessidade de ajuste à altura pretendida. O delineamento experimental foi inteiramente ao acaso. A taxa de lotação apresentou comportamento linear negativo em razão das alturas de pastejo em todas as estações do ano, e o mesmo efeito foi observado com o ganho de peso vivo por hectare, enquanto o ganho médio diário apresentou comportamento contrário. Alturas de capim-tanzânia entre 40 e 60cm, sob lotação contínua, possibilitam bom ganho de peso médio diário em bovinos de corte e boa produção por hectare...


This study was carried out to evaluate the effects of four grazing heights under continuous stocking of Tanzânia grass (Panicum maximum Jacq. Cv. Tanzânia) on the stocking rate, performance and beef production per hectare. The experimental area was 12 hectares, divided into paddocks with one hectare each, with three replicates each (20, 40, 60 and 80 cm). There were three male Nellore bovines per paddock, adding animals as needed to adjust the desired heights in a completely randomized design. The stocking rate had a negative linear function of grazing heights in all seasons regarding yield per hectare, while the average daily gain showed opposite behavior. Apparently, Tanzânia grass heights between 40 and 60cm under continuous stocking enable good average daily weight gain in beef cattle, and high yield per hectare...


Subject(s)
Animals , Cattle , Animal Feed , Cattle/growth & development , Weight Gain/physiology , Panicum/growth & development , Pasture , Population Density
3.
RNC ; 13(1): 19-27, ene.-mar. 2004. tab
Article in Spanish | LILACS | ID: lil-383698

ABSTRACT

La malnutrición calórico-protéica (MCP) es frecuente entre los pacientes con hepatopatías crónicas (HC) estableciéndose hasta en un 80 por ciento. El problema es multifactorial, siendo la disminución de la ingesta una de las causas más relevantes. Objetivo: evaluar la ingesta calórico-protéica en pacientes con HC. Se evaluaron prospectivamente 60 pacientes (26 mujeres, 43,3 por ciento) con una edad media de 54,1 años, con los siguientes diagnósticos: cirrosis biliar primaria 11 (18,3 por ciento), cirrosis alcohólica 26 (46,3 por ciento), hepatopatías autoinmunes 12 (20 por ciento), cirrosis criptogenética 6 (10 por ciento), Budd-Chiari 1 (1,7 por ciento), Hemocromatosis 1 (1,7 por ciento), cirrosis viral 3 (5 por ciento). Se utilizó el recordatorio de 3 días para la recolección de datos de ingesta, la evaluación global subjetiva EGS) para evaluación nutricional y la clasificación de Child-Pugh para evaluar severidad de la hepatopatía...


Subject(s)
Humans , Male , Female , Middle Aged , Protein-Energy Malnutrition , Energy Intake , Liver Diseases , Chronic Disease
4.
Acta gastroenterol. latinoam ; 30(2): 77-84, 2000. tab
Article in Spanish | LILACS | ID: lil-269939

ABSTRACT

Se analizaron los datos epidemiológicos y clínico-evolutivos de la hepatotoxicidad por fármacos en una experiencia de 10 años (1988-1998) de nuestra Unidad de Hígado, que incluye 10342 historias clínicas de registro prospectivo. La prevalencia en este material fué de 5,6 por ciento, con ligero predominio femenino (1.4:1) y en mayores de 40 años; más del 50 por ciento ingirieron 2 o más fármacos. Predominaron las formas agudas (91.4 por ciento) e ictéricas (60.4 por ciento) con manifestaciones sistémicas de hipersensibilidad en 29.3 por ciento, el 4.5 por ciento de las formas agudas se presentaron como fallo hepático agudo severo, con necesidad de transplante hepático en un caso. los 4 casos de hepatitis crónica presentaron evolución a la cirrosis en un caso, y un caso de colestasis con ductopenia (CBP-simil) evolucionó favorablemente en 19 semanas, recibiendo ácido ursode-soxicólico 10 mg/k/día. Seis fármacos representaron el 53.4 por ciento de los casos: anticonceptivos orales, isoniacida, sulfamidas, clorpropamida, carbamacepina y amiodarona.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Liver Diseases/chemically induced , Liver Diseases/epidemiology , Acute Disease , Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Anti-Infective Agents/adverse effects , Anticonvulsants/adverse effects , Antitubercular Agents/adverse effects , Carbamazepine/adverse effects , Chemical and Drug Induced Liver Injury/epidemiology , Cholestasis/chemically induced , Cholestasis/epidemiology , Chronic Disease , Contraceptives, Oral/adverse effects , Hypoglycemic Agents/adverse effects , Isoniazid/adverse effects , Prevalence , Sulfones/adverse effects
5.
Acta gastroenterol. latinoam ; 27(1): 15-8, mar. 1997. tab
Article in Spanish | LILACS | ID: lil-196658

ABSTRACT

In order to have knowledge on the histopatologic characteristics of the HCV infections in our geographical area and its relation with some epidemiologic variables, a serie of 54 biopsias of Anti HCV (R) patients was analized. The histologic lesions found in this study correspond mostly to patients with relatively early infections, on the contrary to other studies of the some kind. The most frequent histopathologic diagnosis were crhonic hepatitis 38/54 (70.4 percent), steatosis 4/54 (7.4 percent) and 12/54 (22.2 percent) with no changes. The presence of lymphoid follicles in the portal tracts was the most frequent histological change in this series (66.7 percent), followed by the alteration in bile ducts (53.7 percent); they occurred in a significally higher proportion in the biopsies which had a diagnosis of chronic hepatitis (p=0.02) (p=0.000002). The presence of steatosis and acidophilic bodies in the acinus were found in nearly one third of the biopsies. This findings suggest that the hepatic damage in the anti HCV reactive patients might take through inmunologic mechanisms and citopatic direct action. It was not found that histologic changes produced by HCV might differ according to epidemiologic variables (post-tranfutional, drug abuse IV and sporadic).


Subject(s)
Adult , Middle Aged , Female , Humans , Hepatitis C/pathology , Liver/pathology , Argentina/epidemiology , Biopsy , Chi-Square Distribution , Epidemiologic Factors , Hepatitis C Antibodies/blood , Hepatitis C/epidemiology
6.
Acta gastroenterol. latinoam ; 26(4): 211-4, 1996. tab
Article in Spanish | LILACS | ID: lil-197171

ABSTRACT

Se presenta un estudio prospectivo sobre 115 alcohólicos crónicos destinado a conocer la prevalencia de marcadores séricos de virus de hepatitis B y C (HBV) (HCV) en ese tipo de pacientes, la asociación de las infecciones por HBV y HCV con diversas variables epidemiológicas y la influencia de esos virus sobre el grado de lesión hepatica. Se halló una prevalencia de marcadores de HBV del 13.9 por ciento de Anti HCV del 20.0 por ciento ambas significativamente mayores a las de los donantes de sangre. La alta prevalencia de Anti HCV en esta serie de alcohólicos, con un 69.6 por ciento de formas espor dicas de infección, resulta difícil de justificar. El diagnóstico histológico de hepatitis crónica (HC) realizado en 3 de los 115 pacientes estudiados, recayó la totalidad de las veces sobre pacientes Anti HCV (R), demonstrando una clara asociación de las HC con el HCV en los alcohólicos crónicos. Con respecto a los otros diagnósticos histológicos, no se halló diferencias entre los pacientes con sueros reactivos para algún marcador del HBV o para el Anti HCV y aquellos con sueros no reactivos; sugiriendo que el HBV y el HCV no influyen en el grado de lesión hep tica de los alcohólicos crónicos. No hallamos que la relación de positividad del Anti HCV en los 23 pacientes fuera diferente según los distintos diagnósticos histopatológicos. Tampoco apreciamos en esta serie, que la cirrosis acurriera mas tempranamente en los Anti HCV R que en los NR; discrepando con algunas comunicaciones recientes.


Subject(s)
Adult , Middle Aged , Female , Humans , Adolescent , Hepacivirus , Hepatitis B virus , Hepatitis, Alcoholic/epidemiology , Liver Diseases, Alcoholic/epidemiology , Argentina/epidemiology , Biomarkers/blood , Chi-Square Distribution , Hepatitis, Alcoholic/blood , Hepatitis, Alcoholic/pathology , Liver Diseases, Alcoholic/pathology , Prevalence , Prospective Studies
7.
Acta gastroenterol. latinoam ; 24(5): 291-6, 1994. tab, graf
Article in Spanish | LILACS | ID: lil-143904

ABSTRACT

La infección por virus de hepatitis B (HBC) y C (HCV) en hemodializados es elevada, y genera problemas epidemiológicos, aumento de la morbilidad y menores expectativas de éxito para el transplante renal; de hecho, la vacunación anti HBV es una indicación racional para este grupo de pacientes, aunque su respuesta es variable. En esta comunciación se analiza el impacto de esta problemática en nuestro medio. Se presentan 219 pacientes (132 del sexo masculino) hemodializados en nuestro hospital y unidades privadas de nuestra ciudad, con edad media de 46,9 años (R=14-85); la media de permanencia en diálisis fue de 20 meses, y la de transfusiones de 5 por ciento/años. En todos los casos se investigó por enzimo-inmunoanálisis (EIA) la presencia en suero de HBs Ag, anti HBs y anti HBc, y en 73 pacientes anti HCV por EIA II; en los casos HBs Ag positivos confirmados se determinó HBe Ag y HBe, y los anti HCV reactivos fueron confirmados por immunobloting de Péptidos Sintéticos LIA-TEK Organon Teknika. Recibieron 40 mcg de vacuna anti HBC recombinante intra deltoidea a 0,1 y 6 meses, 81 pacientes sin marcadores HBC en suero; la respuesta anti HBstitulada dos meses depués de la última dosis fue considerada protectora con títulos superiores a 10µ/ml. La prevalencia de anti HBc y anti HBs fue de 38 por ciento y la de HBs Ag de 21 por ciento; 78 por ciento de los evaluados resultaron reactivos a HBe Ag. La reactividad anti HCV se presentó en 35.6 por ciento, confirmada por LIA (9,7 por ciento en nuestro hospital y 54,8 por unidades privadas con p=0.007). Se halló niveles superiores a 10 mu/ml de anti HBs en 49 por ciento vacunados en los que se tituló el mismo. Los 12 casos restantes (14,8 por ciento) experimentaron hepatitis aguda B durante el período de vacunación...


Subject(s)
Adolescent , Adult , Middle Aged , Humans , Male , Female , Renal Dialysis/adverse effects , Hepatitis B Vaccines/therapeutic use , Hepatitis B/prevention & control , Hepatitis C/prevention & control , Aged, 80 and over , Hepatitis B Antigens/blood , Epidemiologic Factors , Hepatitis B Antibodies/blood , Hepatitis B/epidemiology , Hepatitis B/transmission , Hepatitis C/epidemiology , Hepatitis C/transmission , Biomarkers/blood , Prevalence , Time Factors , Blood Transfusion/adverse effects
8.
Acta gastroenterol. latinoam ; 25(5): 291-6, 1994.
Article in Spanish | LILACS-Express | LILACS, BINACIS | ID: biblio-1157280

ABSTRACT

Data from 219 hemodyalized patients receiving attention in our Hospital and other private centers in our city are shown. Mean age was 46.9 (range: 14-85), and 132 were male; mean time under dialysis was 20 months, and subjects received an average of 5 transfusions per patient year. Serological reactivity to HBs Ag, Anti HBs and IgG anti HBc by ELISA were investigated in all of them, and anti HCV by second generation enzimo-immunoassay (EIA II) in 73 HBe Ag/anti HBe system were determined in HBs Ag positive patients and those reactive to anti HCV (EIA II) were confirmed by LIA (immunoblotting of synthetic peptides LIA-TEK Organos Teknica). Recombinant anti HBV vaccine 40 mcg at 0-1 and six month were received by 81 cases without HBV markers in their sera and a protective response was considered when anti HBs titration of 10 mU/ml or more were obtained two months later. Prevalence for anti HBc and anti HBs were 38.8


respectively and that for HBs Ag was 21


of them reactive for HBs Ag. True reactivity for anti HCV (confirmed by LIA) was present in 35.6


in our Hospital and 54.8


in private units (p < 0.0002). Anti HBs titration was done in 69/81 patients who received anti HBV vaccine, and a protective response in 49


were obtained; the other 12 patients underwent acute hepatitis B during the vaccination period.(ABSTRACT TRUNCATED AT 250 WORDS)

SELECTION OF CITATIONS
SEARCH DETAIL